retatrutide safety profile clinical trials approval: FDA status, trial results, and when it could be available Retatrutide—A Game Changer in Obesity

Advanced Sourcing Benchmarks: Reta vs

Understanding how GLP-1 injections affect your palate helps you prepare for treatment and manage expectations

Some experience from drug repurposing in cancer: Norman Fixel Institute for Neurological Diseases Parkinson's Foundation International Parkinson and Movement Disorder Society American Academy of Neurology

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are widely used in T2DM management due to their ability to lower HbA1c, promote weight loss, and offer cardiovascular and renal protection

No clinical evidence supports this combination

GLP-1 drugs shown cost-effective for knee osteoarthritis and obesity A new study led by investigators at Mass General Brigham finds that adding novel weight loss GLP-1 drugs semaglutide and tirzepatide to usual care represents a cost-effective treatment strategy for people with knee osteoarthritis and obesity, with tirzepatide providing greater health benefits at lower cost compared to semaglutide